Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study
Kenichi Fujii,Stephane Carlier,Gary S. Mintz,Yi-ming Yang,Issam Moussa,Giora Weisz,George Dangas,Roxana Mehran,Alexandra J. Lansky,Edward M. Kreps,Michael B. Collins,Gregg W. Stone,Jeffrey W. Moses,Martin B. Leon +13 more
TLDR
In this article, the predictors of stent thrombosis after sirolimus-eluting stent (SES) implantation were determined. But, their results were limited to 15 patients who developed STC after successful SES implantation.About:
This article is published in Journal of the American College of Cardiology.The article was published on 2005-04-05 and is currently open access. It has received 719 citations till now. The article focuses on the topics: Stent & Intravascular ultrasound.read more
Citations
More filters
Journal ArticleDOI
Pathology of Drug-Eluting Stents in Humans: Delayed Healing and Late Thrombotic Risk
Michael Joner,Aloke V. Finn,Andrew Farb,Erik Mont,Frank D. Kolodgie,Elena Ladich,Robert Kutys,Kristi Skorija,Herman K. Gold,Renu Virmani +9 more
TL;DR: The Cypher and Taxus DES result in delayed arterial healing when compared with BMS of similar implant duration, and the cause of DES LST is multifactorial with delayed healing in combination with other clinical and procedural risk factors playing a role.
Journal ArticleDOI
Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden
TL;DR: Drug-eluting stents were associated with an increased rate of death, as compared with bare-metal stents, and the long-term safety of drug-eluted stents needs to be ascertained in large, randomized trials.
Journal ArticleDOI
Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications
Thomas F. Lüscher,Jan Steffel,Franz R. Eberli,Michael Joner,Gaku Nakazawa,Felix C. Tanner,Renu Virmani +6 more
TL;DR: Evidence of a substantially higher risk of stent thrombosis in drug-eluting stents in DES remains inconclusive; as a consequence, both large-scale and long-term clinical trials are needed.
Journal ArticleDOI
Coronary stents: a materials perspective.
TL;DR: This review focuses on the following topics: different materials used for stents, surface characteristics that influence stent-biology interactions, the use of polymers in stenting, and drug-elutingStents, especially those that are commercially available.
Journal ArticleDOI
Incomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent Implantation
Stéphane Cook,Peter Wenaweser,Mario Togni,Michael Billinger,Cyrill Morger,Christian Seiler,Rolf Vogel,Otto M. Hess,Bernhard Meier,Stephan Windecker +9 more
TL;DR: Incomplete stent apposition is highly prevalent in patients with very late stent thrombosis after DES implantation, suggesting a role in the pathogenesis of this adverse event.
References
More filters
Journal ArticleDOI
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
Jeffrey W. Moses,Martin B. Leon,Jeffrey J. Popma,Peter J. Fitzgerald,David R. Holmes,Charles O'Shaughnessy,Ronald P. Caputo,Dean J. Kereiakes,David O. Williams,Paul S. Teirstein,Judith Jaeger,Richard E. Kuntz +11 more
TL;DR: In this randomized clinical trial involving patients with complex coronary lesions, the use of a sirolimus-eluting stent had a consistent treatment effect, reducing the rates of restenosis and associated clinical events in all subgroups analyzed.
Journal ArticleDOI
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
Marie-Claude Morice,Patrick W. Serruys,J. Eduardo Sousa,Jean Fajadet,Ernesto Ban Hayashi,Marco Antonio Perin,Antonio Colombo,Gerhard Schuler,Paul Barragan,Giulio Guagliumi,Ferenc Molnar,Robert Falotico +11 more
TL;DR: As compared with a standard coronary stent, a sirolimus-eluting stent shows considerable promise for the prevention of neointimal proliferation, restenosis, and associated clinical events.
Journal ArticleDOI
Stent Thrombosis in the Modern Era A Pooled Analysis of Multicenter Coronary Stent Clinical Trials
Donald E. Cutlip,Donald S. Baim,Kalon K.L. Ho,Jeffrey J. Popma,Alexandra J. Lansky,David J. Cohen,Joseph P. Carrozza,Manish S. Chauhan,Orlando Rodriguez,Richard E. Kuntz +9 more
TL;DR: Six recently completed coronary stent trials and associated nonrandomized registries that enrolled 6186 patients treated with ≥1 coronary stents followed by antiplatelet therapy with aspirin and ticlopidine were pooled for this analysis and the variables most significantly associated with the probability of stent thrombosis were persistent dissection NHLBI grade B or higher after stenting.
Journal ArticleDOI
Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study
J. Eduardo Sousa,Marco A. Costa,Alexandre Abizaid,Andrea Abizaid,Fausto Feres,Ibraim Francisco Pinto,Ana C. Seixas,Rodolfo Staico,Luiz Alberto Mattos,Amanda G. M. R. Sousa,Robert Falotico,Judith Jaeger,Jeffrey J. Popma,Patrick W. Serruys +13 more
TL;DR: In this article, the safety and efficacy of sirolimus-coated BX Velocity stents were evaluated in 30 patients with angina pectoris electively treated with two different formulations of SIROlimuscoated stents (slow release and fast release).
Journal ArticleDOI
Predictors of Subacute Stent Thrombosis Results of a Systematic Intravascular Ultrasound Study
Edouard Cheneau,Laurent Leborgne,Gary S. Mintz,Jun-ichi Kotani,Augusto D. Pichard,Lowell F. Satler,Daniel A. Canos,Marco T. Castagna,Neil J. Weissman,Ron Waksman +9 more
TL;DR: Subacute stent thrombosis is infrequently related to the preintervention lesion characteristics, and inadequate postprocedure lumen dimensions, alone or in combination with other procedurally related abnormal lesion morphologies contribute to this phenomenon.